Company Atossa Genetics Inc Nasdaq
Equities
US04962H1005
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
|
Jul. 02 | Atossa Therapeutics Names Heather Rees CFO | MT |
Jul. 02 | Atossa Therapeutics, Inc. Appoints Heather Rees as Chief Financial Officer | CI |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Shu-Chih Chen
FOU | Founder | 62 | 08-11-30 |
Steven Quay
CEO | Chief Executive Officer | 73 | 08-11-30 |
Heather Rees
DFI | Director of Finance/CFO | 51 | 16-12-31 |
Arezoo Mirad
CTO | Chief Tech/Sci/R&D Officer | - | Dec. 03 |
Richard Graydon
CTO | Chief Tech/Sci/R&D Officer | - | 22-10-24 |
Delly Behen
ADM | Chief Administrative Officer | - | 13-12-31 |
Eric van Zanten
IRC | Investor Relations Contact | - | 22-12-06 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Steven Quay
CEO | Chief Executive Officer | 73 | 08-11-30 |
Director/Board Member | 66 | 14-02-28 | |
H. Remmel
BRD | Director/Board Member | 72 | 12-01-31 |
Shu-Chih Chen
FOU | Founder | 62 | 08-11-30 |
Stephen Galli
BRD | Director/Board Member | 77 | 11-06-30 |
Jonathan Finn
BRD | Director/Board Member | 50 | Nov. 07 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 127,077,462 | 125,684,004 ( 98.90 %) | 1,320,046 ( 1.039 %) | 98.90 % |
Stock B | 0 | 582 | 0 | 0 |
Company contact information
Atossa Therapeutics, Inc.
107 Spring Street
98104, Seattle
+206 588 0256
http://www.atossatherapeutics.com![address Atossa Genetics Inc](https://cdn.zonebourse.com/static/address/11461775.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+25.83% | 46.56B | |
+45.38% | 41.67B | |
+0.69% | 41.16B | |
+30.52% | 32.4B | |
+22.30% | 28.18B | |
-6.35% | 28.1B | |
+49.25% | 14.52B | |
+49.18% | 13.74B | |
+3.45% | 12.17B |
- Stock Market
- Equities
- ATOS Stock
- Stock
- Company Atossa Genetics Inc